Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENFORTUMAB VEDOTIN vs ENTRECTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ENFORTUMAB VEDOTIN vs ENTRECTINIB: Safety Overview

Metric ENFORTUMAB VEDOTIN ENTRECTINIB
Total FAERS Reports 1,425 1,491
Deaths Reported 278 246
Death Rate 19.5% 16.5%
Hospitalizations 645 316
Average Patient Age 70.1 yrs 59.8 yrs
% Female Patients 22.5% 58.1%
FDA Approval Date N/A Aug 15, 2019
Manufacturer SEAGEN INC. Genentech, Inc.
Route INTRAVENOUS ORAL
Marketing Status N/A Prescription